Clinical Trials Browser

Phase 4 × Oncogenic osteomalacia × burosumab × Clear all

NCT05357573 2024-07-09

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Phase 4 Completed

Oncogenic osteomalacia